β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
β-cell death is regarded as a major event driving loss of insulin secretion and hyperglycemia in both type 1 and type 2 diabetes mellitus. In this review, we explore past, present, and potential future advances in our understanding of the mechanisms that promote β-cell death in diabetes, with a focu...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/000cf9e0f4544ba29b9b5b9d7f2b65ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:000cf9e0f4544ba29b9b5b9d7f2b65ec |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:000cf9e0f4544ba29b9b5b9d7f2b65ec2021-11-25T18:20:59Zβ-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances10.3390/metabo111107962218-1989https://doaj.org/article/000cf9e0f4544ba29b9b5b9d7f2b65ec2021-11-01T00:00:00Zhttps://www.mdpi.com/2218-1989/11/11/796https://doaj.org/toc/2218-1989β-cell death is regarded as a major event driving loss of insulin secretion and hyperglycemia in both type 1 and type 2 diabetes mellitus. In this review, we explore past, present, and potential future advances in our understanding of the mechanisms that promote β-cell death in diabetes, with a focus on the primary literature. We first review discoveries of insulin insufficiency, β-cell loss, and β-cell death in human diabetes. We discuss findings in humans and mouse models of diabetes related to autoimmune-associated β-cell loss and the roles of autoreactive T cells, B cells, and the β cell itself in this process. We review discoveries of the molecular mechanisms that underlie β-cell death-inducing stimuli, including proinflammatory cytokines, islet amyloid formation, ER stress, oxidative stress, glucotoxicity, and lipotoxicity. Finally, we explore recent perspectives on β-cell death in diabetes, including: (1) the role of the β cell in its own demise, (2) methods and terminology for identifying diverse mechanisms of β-cell death, and (3) whether non-canonical forms of β-cell death, such as regulated necrosis, contribute to islet inflammation and β-cell loss in diabetes. We believe new perspectives on the mechanisms of β-cell death in diabetes will provide a better understanding of this pathological process and may lead to new therapeutic strategies to protect β cells in the setting of diabetes.Noyonika MukherjeeLi LinChristopher J. ContrerasAndrew T. TemplinMDPI AGarticleβ cellcell deathisletdiabetes mellituscytotoxicityMicrobiologyQR1-502ENMetabolites, Vol 11, Iss 796, p 796 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
β cell cell death islet diabetes mellitus cytotoxicity Microbiology QR1-502 |
spellingShingle |
β cell cell death islet diabetes mellitus cytotoxicity Microbiology QR1-502 Noyonika Mukherjee Li Lin Christopher J. Contreras Andrew T. Templin β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
description |
β-cell death is regarded as a major event driving loss of insulin secretion and hyperglycemia in both type 1 and type 2 diabetes mellitus. In this review, we explore past, present, and potential future advances in our understanding of the mechanisms that promote β-cell death in diabetes, with a focus on the primary literature. We first review discoveries of insulin insufficiency, β-cell loss, and β-cell death in human diabetes. We discuss findings in humans and mouse models of diabetes related to autoimmune-associated β-cell loss and the roles of autoreactive T cells, B cells, and the β cell itself in this process. We review discoveries of the molecular mechanisms that underlie β-cell death-inducing stimuli, including proinflammatory cytokines, islet amyloid formation, ER stress, oxidative stress, glucotoxicity, and lipotoxicity. Finally, we explore recent perspectives on β-cell death in diabetes, including: (1) the role of the β cell in its own demise, (2) methods and terminology for identifying diverse mechanisms of β-cell death, and (3) whether non-canonical forms of β-cell death, such as regulated necrosis, contribute to islet inflammation and β-cell loss in diabetes. We believe new perspectives on the mechanisms of β-cell death in diabetes will provide a better understanding of this pathological process and may lead to new therapeutic strategies to protect β cells in the setting of diabetes. |
format |
article |
author |
Noyonika Mukherjee Li Lin Christopher J. Contreras Andrew T. Templin |
author_facet |
Noyonika Mukherjee Li Lin Christopher J. Contreras Andrew T. Templin |
author_sort |
Noyonika Mukherjee |
title |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
title_short |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
title_full |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
title_fullStr |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
title_full_unstemmed |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances |
title_sort |
β-cell death in diabetes: past discoveries, present understanding, and potential future advances |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/000cf9e0f4544ba29b9b5b9d7f2b65ec |
work_keys_str_mv |
AT noyonikamukherjee bcelldeathindiabetespastdiscoveriespresentunderstandingandpotentialfutureadvances AT lilin bcelldeathindiabetespastdiscoveriespresentunderstandingandpotentialfutureadvances AT christopherjcontreras bcelldeathindiabetespastdiscoveriespresentunderstandingandpotentialfutureadvances AT andrewttemplin bcelldeathindiabetespastdiscoveriespresentunderstandingandpotentialfutureadvances |
_version_ |
1718411298095497216 |